Published in Am J Epidemiol on January 01, 1980
School-located influenza vaccination decreases laboratory-confirmed influenza and improves school attendance. Clin Infect Dis (2014) 1.70
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children. J Infect Dis (2013) 1.70
Influenza surveillance in Korea: establishment and first results of an epidemiological and virological surveillance scheme. Epidemiol Infect (2007) 1.60
A primer on strategies for prevention and control of seasonal and pandemic influenza. Am J Public Health (2009) 1.13
A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years. J Infect Dis (2013) 1.06
Age and secular distributions of virus-proven influenza patients in successive epidemics 1961-1976 in Cirencester: epidemiological significance discussed. J Hyg (Lond) (1984) 0.92
Infectious disease in a total institution: a study of the influenza epidemic of 1978 on a college campus. Public Health Rep (1982) 0.91
Clinical outcomes of seasonal influenza and pandemic influenza A (H1N1) in pediatric inpatients. BMC Pediatr (2010) 0.91
Comparison of the HA genes of type B influenza viruses in herald waves and later epidemic seasons. Epidemiol Infect (1992) 0.88
Genetic relationship between the HA genes of type A influenza viruses isolated in off-seasons and later epidemic seasons. Epidemiol Infect (1991) 0.86
Viruses and indoor air pollution. Bull N Y Acad Med (1981) 0.85
Surveillance of influenza in Houston, Texas, USA: gradual transition from A/Victoria/75 (H3N2) to A/Texas/77 (H3N2) predominance and antigenic characterization of "intermediate" strains. Bull World Health Organ (1983) 0.83
Evaluation of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young children. J Clin Microbiol (1992) 0.83
Antigenic analysis of H1N1 viruses isolated in the Houston metropolitan area during four successive seasons. Infect Immun (1983) 0.81
Influenza and school-based influenza-like illness surveillance: a pilot initiative in Maryland. Public Health Rep (2011) 0.80
Relative timing of influenza disease by age group. Vaccine (2014) 0.79
Selected laboratory aspects of influenza surveillance. Yale J Biol Med (1983) 0.76
A 'herald wave' of type A influenza of the H1N1 sub-type. J R Coll Gen Pract (1986) 0.75
Automated microbiological detection/identification system. J Clin Microbiol (1977) 16.88
The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med (2001) 7.49
Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child (1986) 7.39
A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol (1970) 4.12
Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev (1982) 4.03
Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr (1981) 4.00
Mortality and influenza. J Infect Dis (1982) 3.98
Interpandemic influenza in the Houston area, 1974-76. N Engl J Med (1978) 3.92
Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. J Infect Dis (1971) 3.73
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA (1999) 3.53
Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA (2000) 3.50
Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis (1981) 3.30
Immunity to influenza in man. Annu Rev Microbiol (1983) 3.22
Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement. J Clin Microbiol (1980) 3.10
Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses. J Clin Microbiol (1979) 3.05
Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics (1983) 3.00
Ribavirin small-particle aerosol treatment of influenza. Lancet (1981) 2.91
Comparison of reverse transcription-PCR with tissue culture and other rapid diagnostic assays for detection of type A influenza virus. J Clin Microbiol (1996) 2.77
Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. J Pediatr (1971) 2.75
Induction of partial immunity to influenza by a neuraminidase-specific vaccine. J Infect Dis (1974) 2.66
Assessment of experimental and natural viral aerosols. Bacteriol Rev (1966) 2.64
Comparison of rapid diagnostic techniques for respiratory syncytial and influenza A virus respiratory infections in young children. J Clin Microbiol (1993) 2.50
Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis (1980) 2.50
A 12 year review of the antibiotic management of Hemophilus influenzae meningitis. Comparison of ampicillin and conventional therapy including chloramphenicol. J Pediatr (1972) 2.48
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. Infect Immun (1980) 2.42
Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission. Bacteriol Rev (1966) 2.41
Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J Infect Dis (1984) 2.31
Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children. J Pediatr (1975) 2.29
Sporadic occurrence of zoonotic swine influenza virus infections. J Clin Microbiol (1984) 2.24
Effects of low- and high-passage influenza virus infection in normal and nude mice. Infect Immun (1977) 2.24
Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. J Clin Invest (1977) 2.23
Prolonged pneumococcal meningitis due to an organism with increased resistance to penicillin. Pediatrics (1976) 2.22
Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man. J Infect Dis (1971) 2.13
Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis (1996) 2.12
The role of nasal secretion and serum antibody in the rhinovirus common cold. Am J Epidemiol (1966) 2.11
Protein composition of nasal secretion during respiratory virus infection. Proc Soc Exp Biol Med (1965) 2.03
Respiratory disease in group day care. Pediatrics (1972) 2.01
Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis (1996) 1.98
Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine (1997) 1.95
Developing gap in immunity to poliomyelitis in an urban area. JAMA (1969) 1.89
Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Respir Dis (1987) 1.84
Seroepidemiological and ecological studies of the adenovirus-associated satellite viruses. Infect Immun (1970) 1.78
Value of the C-reactive protein test in the differentiation of bacterial and viral pneumonia. J Pediatr (1978) 1.76
Influenza virus infections in infants. Pediatr Infect Dis J (1997) 1.75
The influenza herald wave. Am J Epidemiol (1982) 1.74
Influenza in children. Relationship to other respiratory agents. JAMA (1980) 1.73
Maintenance of viability and comparison of identification methods for influenza and other respiratory viruses of humans. J Clin Microbiol (1977) 1.73
Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers. Infect Immun (1973) 1.72
Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer. Ann Oncol (2004) 1.71
Effects of tetracycline on leukotaxis. J Infect Dis (1974) 1.69
Dual respiratory virus infections. Clin Infect Dis (1997) 1.67
Spectrum of clinical illness in hospitalized patients with "common cold" virus infections. Clin Infect Dis (2000) 1.66
Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis (1993) 1.65
Influenza: its control in persons and populations. J Infect Dis (1986) 1.65
Influenza virus subunit vaccines. II. Immunogenicity and original antigenic sin in humans. J Infect Dis (1976) 1.64
Pharmacokinetics of once-daily dosing of gentamicin in neonates. J Pediatr (1997) 1.63
High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults. J Clin Microbiol (1994) 1.61
Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice. Antimicrob Agents Chemother (1980) 1.61
Renal disease in children with the acquired immunodeficiency syndrome. N Engl J Med (1989) 1.60
Rhinovirus neutralizing antibody in tears, parotid saliva, nasal secretions and serum. J Immunol (1967) 1.59
Fulminant neonatal sepsis and necrotizing enterocolitis associated with a "nonenteropathogenic" strain of Escherichia coli. J Pediatr (1976) 1.56
Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child (1990) 1.56
The effects of influenza on host defenses. J Infect Dis (1981) 1.54
Herpes zoster-associated encephalitis: clinicopathologic report of 12 cases and review of the literature. Medicine (Baltimore) (1983) 1.50
Changes in IgA and IgG concentrations in nasal secretions prior to the appearance of antibody during viral respiratory infection in man. J Immunol (1970) 1.49
Group A streptococci, mycoplasmas, and viruses associated with acute pharyngitis. JAMA (1967) 1.47
Maternal immunization against viral disease. Vaccine (1998) 1.47
Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978. Rev Infect Dis (1983) 1.46
Therapy for the divergent pulpless tooth by continued apical formation. J Am Dent Assoc (1966) 1.46
Infection with influenza A/Victoria virus in Houston families, 1976. J Hyg (Lond) (1981) 1.44
Treatment of influenza A (H1N1) virus infection with ribavirin aerosol. Antimicrob Agents Chemother (1984) 1.43
Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84. Antimicrob Agents Chemother (1985) 1.43